ArticleFrontiers in immunology2023

Signaling network analysis reveals fostamatinib as a potential drug to control platelet hyperactivation during SARS-CoV-2 infection.

Özge Osmanoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.